Valuation (29%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -9.56 | 25.02 |
PEG Ratio (TTM) | 0.00 | -0.39 |
P/S Ratio (TTM) | 7.27 | 1.45 |
P/B Ratio (TTM) | 0.85 | 0.95 |
P/FCF Ratio (TTM) | -64.46 | 46.09 |
Price to 5YR AVG Earnings Ratio | N/A | 6.01 |
Price to 5YR AVG FCF Ratio | N/A | 17.23 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.61% | 4.00% |
ROE (TTM) | -8.78% | 6.23% |
Net Profit Margin (TTM) | -13.06% | 4.12% |
ROIC 5YR AVG | N/A | 20.34% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -722.23% | 13.85% | N/A |
Revenue | -15.50% | 36.02% | N/A |
Net Income | -744.56% | 13.42% | N/A |
Cash Flow | 7.31% | 38.18% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.44 | 2.58 |
Quick Ratio (TTM) | 1.16 | 1.47 |
D/E Ratio (TTM) | 0.50 | 0.28 |
Interest Coverage (TTM) | N/A | 26.59 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 6.00 | 4.09 |
LTL to 5YR AVG FCF | N/A | 2.25 |
Shares Outstanding Growth 5YR AVG | N/A | -3.70% |